Literature DB >> 31971771

Analysis of Interactions Stabilized by Fusicoccin A Reveals an Expanded Suite of Potential 14-3-3 Binding Partners.

Ananya Sengupta1, Josue Liriano1, Brian G Miller1, James H Frederich1.   

Abstract

Fusicoccin A (FC) is a diterpene glycoside that stabilizes protein-protein interactions (PPIs) between 14-3-3 adapter proteins and their phosphoprotein interaction partners. Recently, FC has gained attention for its pro-apoptotic and neuroprotective properties in cell culture. Although the exact molecular mechanism(s) is (are) unresolved, 14-3-3 PPIs are central to this activity. With the goal of refining the pharmacology of this chemotype, we conducted a systematic analysis of the structural features that govern FC-induced stabilization of 14-3-3 PPIs utilizing a C-terminal phosphorylation recognition motif. This study confirmed that a C-terminal amino acid with a small alkyl group is required for the interaction of FC at canonical C-terminal 14-3-3 PPI interfaces. Using bioinformatics, this structural insight was leveraged to assemble a database of 119 candidate 14-3-3 PPIs that can serve as targets for FC. This group includes a subset of proteins with experimentally determined C-terminal phosphosites that have not been explored as potential targets of FC.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31971771      PMCID: PMC7169973          DOI: 10.1021/acschembio.9b00795

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  35 in total

1.  Sequence and structure-based prediction of eukaryotic protein phosphorylation sites.

Authors:  N Blom; S Gammeltoft; S Brunak
Journal:  J Mol Biol       Date:  1999-12-17       Impact factor: 5.469

Review 2.  The 14-3-3 cancer connection.

Authors:  Heiko Hermeking
Journal:  Nat Rev Cancer       Date:  2003-12       Impact factor: 60.716

3.  Phosphorylation of p27Kip1 at threonine 198 by p90 ribosomal protein S6 kinases promotes its binding to 14-3-3 and cytoplasmic localization.

Authors:  Naoya Fujita; Saori Sato; Takashi Tsuruo
Journal:  J Biol Chem       Date:  2003-09-22       Impact factor: 5.157

4.  14-3-3 proteins in neurological disorders.

Authors:  Molly Foote; Yi Zhou
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

5.  Phosphorylation-dependent C-terminal binding of 14-3-3 proteins promotes cell surface expression of HIV co-receptor GPR15.

Authors:  Yukari Okamoto; Sojin Shikano
Journal:  J Biol Chem       Date:  2010-12-28       Impact factor: 5.157

Review 6.  C-terminal binding: an expanded repertoire and function of 14-3-3 proteins.

Authors:  Brian Coblitz; Meng Wu; Sojin Shikano; Min Li
Journal:  FEBS Lett       Date:  2006-02-17       Impact factor: 4.124

7.  14-3-3sigma, the double-edged sword of human cancers.

Authors:  Zhaomin Li; Jing-Yuan Liu; Jian-Ting Zhang
Journal:  Am J Transl Res       Date:  2009-06-08       Impact factor: 4.060

8.  Bioinformatic and experimental survey of 14-3-3-binding sites.

Authors:  Catherine Johnson; Sandra Crowther; Margaret J Stafford; David G Campbell; Rachel Toth; Carol MacKintosh
Journal:  Biochem J       Date:  2010-03-15       Impact factor: 3.857

9.  Interaction of 14-3-3 proteins with the estrogen receptor alpha F domain provides a drug target interface.

Authors:  Ingrid J De Vries-van Leeuwen; Daniel da Costa Pereira; Koen D Flach; Sander R Piersma; Christian Haase; David Bier; Zeliha Yalcin; Rob Michalides; K Anton Feenstra; Connie R Jiménez; Tom F A de Greef; Luc Brunsveld; Christian Ottmann; Wilbert Zwart; Albertus H de Boer
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-15       Impact factor: 11.205

10.  TROY (TNFRSF19) promotes glioblastoma survival signaling and therapeutic resistance.

Authors:  Joseph C Loftus; Harshil Dhruv; Serdar Tuncali; Jean Kloss; Zhongbo Yang; Cassie A Schumacher; Brian Cao; Bart O Williams; Jennifer M Eschbacher; Julianna T D Ross; Nhan L Tran
Journal:  Mol Cancer Res       Date:  2013-05-22       Impact factor: 5.852

View more
  5 in total

Review 1.  14-3-3 Proteins: Novel Pharmacological Targets in Neurodegenerative Diseases.

Authors:  F Sanders Pair; Talene A Yacoubian
Journal:  Trends Pharmacol Sci       Date:  2021-01-28       Impact factor: 14.819

2.  Structural insight on assembly-line catalysis in terpene biosynthesis.

Authors:  Jacque L Faylo; Trevor van Eeuwen; Hee Jong Kim; Jose J Gorbea Colón; Benjamin A Garcia; Kenji Murakami; David W Christianson
Journal:  Nat Commun       Date:  2021-06-09       Impact factor: 14.919

3.  Hierarchized phosphotarget binding by the seven human 14-3-3 isoforms.

Authors:  Gergo Gogl; Kristina V Tugaeva; Pascal Eberling; Camille Kostmann; Gilles Trave; Nikolai N Sluchanko
Journal:  Nat Commun       Date:  2021-03-15       Impact factor: 14.919

Review 4.  Assembly-Line Catalysis in Bifunctional Terpene Synthases.

Authors:  Jacque L Faylo; Trey A Ronnebaum; David W Christianson
Journal:  Acc Chem Res       Date:  2021-07-13       Impact factor: 24.466

5.  Probing the 14-3-3 Isoform-Specificity Profile of Protein-Protein Interactions Stabilized by Fusicoccin A.

Authors:  Ananya Sengupta; Josue Liriano; Ewa A Bienkiewicz; Brian G Miller; James H Frederich
Journal:  ACS Omega       Date:  2020-09-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.